- Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staffThe Really Big Neuroscience Company is proving to be a Really Big Flop with each passing update. Neumora Therapeutics will discontinue its lead depression drug after it failed another two Phase 3…Endpoints · 1mo ago↗ source
- Medicare drug price rule may target under-the-skin Keytruda and Opdivo<figure><div><img src="https://imgproxy.divecdn.com/yNFj1iOXXiGXHrvNzMITrI7Zf52PfwK1rovRc0StZW8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMDQ3NTA1MDAwLmpwZ…BioPharma Dive · 1mo ago↗ source
- Six leaders working on LGBTQ+ inclusion in biopharmaIt’s been a tough 18 months for the LGBTQ+ community. The American Civil Liberties Union tracked 530 anti-LGBTQ bills across dozens of states this year. Nearly 40% of US workers say ...